Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report sent to investors on Friday morning. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright restated a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Stock Down 2.1 %

Shares of Arcadia Biosciences stock opened at $2.84 on Friday. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $5.34. The company has a market capitalization of $3.88 million, a P/E ratio of -0.66 and a beta of 1.27. The company has a 50 day moving average of $3.34 and a 200 day moving average of $3.04.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.